What Is an AdCom? One of the Most Overlooked Biotech Events
An AdCom, short for advisory committee meeting, is a public meeting where the FDA asks a panel of outside experts to review a drug, biologic, or medical product and discuss key questions related to safety, efficacy, labeling, or overall benefit-risk balance. These meetings do not directly approve or reject a product, but they can heavily influence perception around the regulatory path.